Jacques Hebert
Overview
Explore the profile of Jacques Hebert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1646
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sousa-Pinto B, Ramanauskaite A, Neisinger S, Witte-Handel E, Gimenez-Arnau A, Guillet C, et al.
Allergy
. 2024 Oct;
80(3):750-761.
PMID: 39445583
Background: CRUSE® is an app that allows patients with chronic spontaneous urticaria (CSU) to monitor their daily disease activity through the use of visual analogue scales (VASs). We aimed to...
2.
Boursiquot J, Chapdelaine H, St-Pierre C, Hebert J
J Immunol Res
. 2024 Mar;
2024:3028617.
PMID: 38487730
Background: Limited data are available on the clinical profile and disease burden of hereditary angioedema (HAE) in Canadians. Objective: This study aimed to assess HAE disease characteristics and the burden...
3.
Marceau F, Rivard G, Hebert J, Gauthier J, Bachelard H, Gangnus T, et al.
Front Allergy
. 2022 Apr;
3:837463.
PMID: 35386662
Background: Hereditary angioedema (HAE) is a rare autosomal dominant disease; the most well understood forms concern the haplodeficiency of C1 esterase inhibitor (C1INH) and a gain of function mutation of...
4.
Hebert J, Boursiquot J, Chapdelaine H, Laramee B, Desjardins M, Gagnon R, et al.
Int J Emerg Med
. 2022 Mar;
15(1):15.
PMID: 35350995
Background: Acute airway angioedema commonly occurs through two distinct mechanisms: histamine- and bradykinin-dependent. Although they respond to distinct treatments, these two potentially life-threatening states present similarly. Poor recognition of the...
5.
Zuberbier T, Abdul Latiff A, Abuzakouk M, Aquilina S, Asero R, Baker D, et al.
Allergy
. 2021 Sep;
77(3):734-766.
PMID: 34536239
This update and revision of the international guideline for urticaria was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group....
6.
Perez E, Hebert J, Ellis A, Alpan O, Lumry W, Shapiro R, et al.
Front Immunol
. 2021 Jul;
12:707463.
PMID: 34305948
We report here the results of a phase 3 study to assess the efficacy, safety, and tolerability of GC5107, a new 10% liquid intravenous immunoglobulin (IVIG) in preventing serious bacterial...
7.
Marceau F, Bachelard H, Charest-Morin X, Hebert J, Rivard G
Pharmaceuticals (Basel)
. 2020 Aug;
13(9).
PMID: 32824891
Kinins (peptides related to bradykinin, BK) are formed from circulating substrates, the kininogens, by the action of two proteases, the kallikreins. The only clinical application of a BK receptor ligand,...
8.
Marceau F, Rivard G, Gauthier J, Binkley K, Bonnefoy A, Boccon-Gibod I, et al.
Front Med (Lausanne)
. 2020 Aug;
7:358.
PMID: 32766265
Bradykinin (BK)-mediated angioedema (AE) states are rare acquired or hereditary conditions involving localized edema of the subcutaneous and submucosal tissues. Citrated plasma from healthy volunteers or patients with hereditary angioedema...
9.
Betschel S, Badiou J, Binkley K, Borici-Mazi R, Hebert J, Kanani A, et al.
Allergy Asthma Clin Immunol
. 2020 May;
16:33.
PMID: 32399057
[This corrects the article DOI: 10.1186/s13223-019-0376-8.].
10.
Sussman G, Hebert J, Gulliver W, Lynde C, Yang W, Papp K, et al.
J Allergy Clin Immunol Pract
. 2020 Apr;
8(7):2372-2378.e5.
PMID: 32272284
Background: Omalizumab shows greater clinical benefit with 300 mg dose than with the 150 mg dose. Objective: To determine outcomes postwithdrawal, relapse, and re-treatment in omalizumab responders, and from stepping...